Vensum Power €9M Series A round led by Lifeline Ventures T-Therapeutics €118.4M ($133M) Series B round led by Advent Life Sciences Granit €3.5M funding round led by Seedcamp Mindmax €3.0M ($3.3M) Pre-seed round led by Concept Ventures FluoRok €26.7M ($30M) Series A round led by Orano Venture Fund Kabilio €10M funding round led by Picus Capital Claimlane €5.6M Series A round led by Verb Ventures Green Voltis €13.5M Series A round led by Lochpine Capital VÆRIDION €30M Series A round led by SHIFT Invest Conlio €6.4M funding round led by Piton Capital 1nhaler €2.7M (£2.2M) funding round led by Archangels Vitroscope €4.5M ($5M) Seed round led by Cerberus Ventures Granter €1.6M funding round led by 3XP Global (via its Impact Innovation Fund Unitoq €160K raises a Pre-seed round CyberKord €2.7M Pre-seed round led by 360 Capital Tumbleweed €6.9M Seed round led by Pact VC Quint Computing €9.1M funding round led by Vsquared Ventures Seamoretech €1.1M raises a Seed round LO:TECH €10.7M ($12M) Series A round led by MMC Ventures Roleo €2.9M funding round led by Practica Capital

Sesame Summit 2027

A

Advent Life Sciences

● Actively deploying London, UK

Pitch this fund Website ↗

Investment thesis

We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach.

Sesamers tracks 1 portfolio company across 1 round, 1 of them as lead investor. Its most recent tracked deal: T-Therapeutics, Nov 2026.

Portfolio

T-Therapeutics Series B · 2026 · Led · Cambridge, United Kingdom

Past investments

Company	Round	Role	Date	Round size
T-Therapeutics Cambridge, United Kingdom Read the announcement →	Series B	Lead	Nov 2026	€118.4M

Sesamers coverage

November 8, 2026

T-Therapeutics raises $133M Series B for TCR bispecifics

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.